CYTK
Price
$45.74
Change
-$1.25 (-2.66%)
Updated
Jan 17 closing price
Capitalization
5.4B
33 days until earnings call
TTNP
Price
$3.83
Change
+$0.70 (+22.29%)
Updated
Jan 17 closing price
Capitalization
3.51M
Ad is loading...

CYTK vs TTNP

Header iconCYTK vs TTNP Comparison
Open Charts CYTK vs TTNPBanner chart's image
Cytokinetics
Price$45.74
Change-$1.25 (-2.66%)
Volume$998.34K
Capitalization5.4B
Titan Pharmaceuticals
Price$3.83
Change+$0.70 (+22.29%)
Volume$119.8K
Capitalization3.51M
CYTK vs TTNP Comparison Chart
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TTNP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. TTNP commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Hold and TTNP is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (CYTK: $45.74 vs. TTNP: $3.84)
Brand notoriety: CYTK and TTNP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 83% vs. TTNP: 368%
Market capitalization -- CYTK: $5.4B vs. TTNP: $3.51M
CYTK [@Biotechnology] is valued at $5.4B. TTNP’s [@Biotechnology] market capitalization is $3.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileTTNP’s FA Score has 0 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • TTNP’s FA Score: 0 green, 5 red.
According to our system of comparison, CYTK is a better buy in the long-term than TTNP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 4 TA indicator(s) are bullish while TTNP’s TA Score has 3 bullish TA indicator(s).

  • CYTK’s TA Score: 4 bullish, 4 bearish.
  • TTNP’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both CYTK and TTNP are a good buy in the short-term.

Price Growth

CYTK (@Biotechnology) experienced а -1.89% price change this week, while TTNP (@Biotechnology) price change was +14.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

CYTK is expected to report earnings on May 07, 2025.

TTNP is expected to report earnings on Feb 28, 2024.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($5.4B) has a higher market cap than TTNP($3.51M). TTNP YTD gains are higher at: 17.638 vs. CYTK (-2.764). CYTK has more cash in the bank: 1.01B vs. TTNP (8.43M). TTNP has less debt than CYTK: TTNP (33K) vs CYTK (790M).
CYTKTTNPCYTK / TTNP
Capitalization5.4B3.51M153,965%
EBITDA-481.94MN/A-
Gain YTD-2.76417.638-16%
P/E RatioN/AN/A-
Revenue3.22MN/A-
Total Cash1.01B8.43M12,009%
Total Debt790M33K2,393,939%
FUNDAMENTALS RATINGS
CYTK vs TTNP: Fundamental Ratings
CYTK
TTNP
OUTLOOK RATING
1..100
7726
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
51100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
8191
P/E GROWTH RATING
1..100
181
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CYTK's Valuation (100) in the Biotechnology industry is in the same range as TTNP (100) in the Pharmaceuticals Major industry. This means that CYTK’s stock grew similarly to TTNP’s over the last 12 months.

CYTK's Profit vs Risk Rating (51) in the Biotechnology industry is somewhat better than the same rating for TTNP (100) in the Pharmaceuticals Major industry. This means that CYTK’s stock grew somewhat faster than TTNP’s over the last 12 months.

TTNP's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as CYTK (100) in the Biotechnology industry. This means that TTNP’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's Price Growth Rating (81) in the Biotechnology industry is in the same range as TTNP (91) in the Pharmaceuticals Major industry. This means that CYTK’s stock grew similarly to TTNP’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for TTNP (81) in the Pharmaceuticals Major industry. This means that CYTK’s stock grew significantly faster than TTNP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYTKTTNP
RSI
ODDS (%)
Bullish Trend 5 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
81%
Momentum
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bearish Trend 5 days ago
74%
Bullish Trend 5 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
78%
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
75%
Bearish Trend 5 days ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
80%
Bullish Trend 12 days ago
79%
Declines
ODDS (%)
Bearish Trend 9 days ago
77%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 5 days ago
77%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Ad is loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TTNP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with TRDA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
-2.66%
TRDA - CYTK
44%
Loosely correlated
+1.20%
ACLX - CYTK
37%
Loosely correlated
-0.79%
MLYS - CYTK
37%
Loosely correlated
-2.74%
PTGX - CYTK
36%
Loosely correlated
+0.77%
APLS - CYTK
36%
Loosely correlated
+0.69%
More

TTNP and

Correlation & Price change

A.I.dvisor indicates that over the last year, TTNP has been loosely correlated with INM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TTNP jumps, then INM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TTNP
1D Price
Change %
TTNP100%
+21.94%
INM - TTNP
47%
Loosely correlated
+10.00%
BPMUF - TTNP
27%
Poorly correlated
N/A
CYTK - TTNP
23%
Poorly correlated
-2.66%
SER - TTNP
22%
Poorly correlated
+1.26%
SPHRY - TTNP
22%
Poorly correlated
+5.96%
More